Highlights from the Ratings and Financial Report for Kinnate Biopharma Inc. (KNTE)

Retrieved on: 2022-10-13 19:53:45

Tags for this article:

Click the tags to see associated articles and topics

Highlights from the Ratings and Financial Report for Kinnate Biopharma Inc. (KNTE). View article details on hiswai:

Excerpt

Kinnate Biopharma Inc. (NASDAQ:KNTE) went down by -26.65% from its latest closing price compared to the recent 1-year high of $26.05.

Article found on: newsheater.com